Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CHU de Martinique (CHUM) is the leading university hospital and healthcare provider in the French West Indies, headquartered in Fort-de-France. As a public health institution, it provides a comprehensive range of specialized medical, surgical, and psychiatric services to the population of Martinique and the wider Caribbean region. The CHUM is a center of excellence for clinical research, particularly in areas such as tropical diseases, sickle cell anemia, and oncology, often collaborating with national research bodies like Inserm. It operates across several specialized sites, including the Pierre Zobda-Quitman Hospital and the Mother and Child Center. In addition to patient care, the institution plays a vital role in medical education and training through its affiliation with the University of the Antilles. The hospital is equipped with advanced medical technologies, including radiotherapy and interventional cardiology units, to address complex health needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CHU de Martinique.